ThomasRSchwabMD

PubMed

• 110 citations
  Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.
  Juan M. Sarmiento, David H. Dockrell, Thomas R Schwab, Stephen R. Munn, Carlos V. Paya
  Clinical Transplantation. 2000-04-01
• 199 citations
  Overcoming a Positive Crossmatch in Living-Donor Kidney Transplantation
  James M. Gloor, Steven R. DeGoey, Alvaro A. Pineda, S. Breanndan Moore, Mikel Prieto
  American Journal of Transplantation. 2003-08-01
• 124 citations
  Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).
  Hani M. Wadei, Andrew D. Rule, M. Lewin, A. S. Mahale, Hasan Khamash
  American Journal of Transplantation. 2006-05-01

Journal Articles

• The outcome of patients with nephrogenic systemic fibrosis after successful kidney transplantation  
  Leung N, Shaikh A, Cosio FG, Griffin MD, Textor SC, Gloor JM, Schwab TR, Larson TS, Dean PG, Prieto M, Nyberg SL, Stegall MD, Lee CU, Pittelkow MR, J Urol, 1/1/2010
• American Renal Trainging Center: Idiopathic Retroperitoneal Fibrosis  
  Schwab TR, Journal of the American Soc of Nephrology, 1/1/1993
• Chronic renal failure  
  Schwab TR, The Practice of Internal Medicine, 5/1/1992
• Atrial endocrine function in humans with artificial hearts  
  Schwab TR, Edwards BS, DeVries WC, Zimmerman RS, Burnett JC Jr, N Engl J Med, 11/1/1986
• Serology in renal disease: a review  
  Schwab TR, Donadio JV Jr, Semin Nephrol, 9/1/1985
• Join now to see all

Books/Book Chapters

• Mayo Clinic internal medicine: concise textbook. 
  Chapter: Nephrology. 
  Page 569 - 611Fervenza FC, Schwab TR, Williams AW, Albright RC Jr, Erickson SBEditors: Habermann TM, Ghosh AK.Mayo Clinic Scientific Press, Rochester, MN2008
• Mayo Clinic internal medicine review. 
  Chapter: Nephrology: part I. 
  Page 691 - 705Fervenza FC, Schwab TREditors: Ghosh AK.Mayo Clinic Scientific Press, Rochester, MNEdition 8th,2008
• Mayo Clinic internal medicine review, 2006-2007. 
  Chapter: Nephrology. 
  Page 647 - 698Fervenza FC, Schwab TR, Williams AW, Albright RC Jr, Erickson SBEditors: Habermann TM.Mayo Clinic Scientific Press, Rochester, MNEdition 7th,2006
• Mayo Clinic internal medicine board review, 2004-2005. 
  Chapter: Nephrology. 
  Page 665 - 719Fervenza FC, Schwab TR, Williams AW, Albright RC, Erickson SBEditors: Habermann TM.Lippincott Williams & Wilkins, Philadelphia, PA2004
• Mayo Clinic internal medicine board review, 2002-2003. 
  Chapter: Nephrology. 
  Page 677 - 726Schwab TR, Williams AW, Albright RC Jr, Erickson SBEditors: Habermann TM.Lippincott Williams & Wilkins, Philadelphia, PAEdition 5th,2002
• Mayo Internal Medicine Board Review 2000-01. 
  Chapter: Nephrology. 
  Page 623 - 658Schwab TR, Erickson SBEditors: Prakash UBS.Lippincott Williams & Wilkins, Philadelphia, PA2000
• Mayo Internal Medicine Board Review 1998-99. 
  Chapter: Nephrology. 
  Page 595 - 628Schwab TREditors: Prakash UBS.Lippincott-Raven Publishers, Philadelphia, PA1998
• Mayo internal medicine board review, 1996-97. 
  Chapter: Nephrology. 
  Page 561 - 590Schwab TREditors: Prakash UBS.Mayo Foundation for Medical Education and Research, Rochester, MNEdition 2nd,1996
• Mayo Internal Medicine Board Review 1994-95 
  Chapter: Nephrology. 
  Page 585 - 612Schwab TREditors: Prakash UBS.Mayo Foundation for Medical Education and Research, Rochester, MN1994
• American Society of Hypertension Series 2: Advances in Biologically Active Atrial Peptides. 
  Chapter: The effect of narcotic administration on plasma atrial natriuretic factor in humans. 
  Page 219 - 221Narr BJ, Schwab TR, Heublein DM, Burnett JC JrEditors: Brenner BM, Laragh JH.Raven Press, New York, NY1988
• Advances in Atrial Peptide Research, Volume 2 
  Chapter: Absence of Diurnal Variation of Atrial Natriuretic Factor in Humans. 
  Page 315 - 318Zimmerman RS, Edwards BS, Schwab TR, Heublein DM, Burnett JC JrEditors: BM Brenner and JH Laragh.Raven Press, New York, NY1988
• Proc of the 1st World Congress of Atrial Peptide 
  Chapter: Cardiac, atrial peptide, and renal responses to acute graded volume expansion. 
  Page 325 - 327Zimmerman RS, Edwards BS, Schwab TR, Heublein DM, Burnett JC, JrEditors: BM Brenner and J Laragh.Raven Press, New York, NY1987
• Proc of the 1st World Congress of Atrial Peptide 
  Chapter: Cardiac effects of atrial natriuretic peptide in-vivo and in-vitro. 
  Page 328 - 330Burnett JC, Jr, Rubanyi GM, Edwards BS, Schwab TR, Zimmerman RS, Vanhoutte PMEditors: BM Brenner and J Laragh.Raven Press, New York, NY1987
• Proc of the 1st World Congress of Atrial Peptide 
  Chapter: Renal interstitial hydrostatic pressure dyanmics during atrial natriuretic peptide adminstration. 
  Page 413 - 415Schwab TR, Edwards BS, Zimmerman RS, Hueblein DM, Burnett JC JrEditors: BM Brenner and J Laragh.Raven Press, New York, NY1987
• Proc of the 1st World Congress of Atrial Peptide 
  Chapter: Human platelet-rich and platelet-poor plasma atrial natriuretic peptide levels during dehydration. 
  Page 467 - 469Heublein DM, Schwab TR, Edwards BS, Zimmerman RS, Heser D, Kao PC, Burnett JC, JrEditors: BM Brenner and J Laragh.Raven Press, New York, NY1987
• Join now to see all

Abstracts/Posters

• Establishing a clinical hand transplant program.
  Amer H, Rynerson N, Fix L, Casey E, Schwab MK, Avikanen BF, Rosen CB, Edwards BS, Bengtson KA, Morrey MA, Jowsey SG, Schwab TR, Carlsen BT, Moran SL, Stewart S, Transpl Int, 9/1/2011
• Hand transplantation in the realm of clinical practice.
  Amer H, Carlsen BT, Jowsey SG, Bengston KA, Rosen CB, Jurrison ML, Avikanen BF, Morrey MA, Schwab TR, Edwards BS, Moran SL, Am J Transplant, 4/1/2011
• Cidofavir therapy for polyomavirus-associated nephropathy: factors associated with clinical response (Abstract 464).
  Wadei HM, Arif F, Khamash HA, Mahale AS, Dean PG, Espy MJ, Lewin M, Cosio FG, Gloor JM, Schwab TR, Textor SC, Smith TF, Larson TS, Stegall MD, Griffin MD, Am J Transplant, 1/1/2005
• Determinants of kidney graft function during the first two years post-transplant (Abstract 1161).
  Cosio FG, Griffin MD, Schwab TR, Gloor JM, Velosa JA, Textor S, Stegall MS, Larson TS, Am J Transplant, 1/1/2004
• The spectrum of chronic histologic abnormalities in living donor kidney transplants at the time of implantation: correlation with donor and recipient clinical data (Ab...
  Diaz Encarnacion MM, Griffin MD, Textor SC, Cosio FC, Gregoire JR, Schwab TR, Gloor JM, Taler SJ, Larson TS, Stegall MD, Grande JP, Am J Transplant, 1/1/2004
• Sequential living donor kidney and autologous stem cell transplantation for AL ("primary") amyloidosis with predominant renal involvement (Abstract 1172).
  Griffin MD, Leung N, Dispenzieri A, Gloor JM, Schwab TR, Textor SC, Lacy MQ, Litzow MR, Larson TS, Gertz MA, Stegall MD, Am J Transplant, 1/1/2004
• BK nephropathy managed by reduced immunosuppression: progressive loss of graft function is dictated by timing of diagnosis and by extent of the initial fibrotic injury...
  Khamash HA, Mahale A, Buehrig CK, Coisio FC, Lager DJ, Fidler ME, Schwab TR, Gloor JM, Taler SJ, Textor SC, Stegall MD, Larson TS, Griffin MD, Am J Transplant, 1/1/2004
• Factors associated with development of BK nephropathy among patients receiving kidney transplants at a single center during 2001 (Abstract 1562).
  Khamash HA, Mahale A, Buehrig CK, Cosio FC, Lager DJ, Fidler ME, Schwab TR, Gloor JM, Taler SJ, Textor SC, Stegall MD, Larson TS, Griffin MD, Am J Transplant, 1/1/2004
• Preserving renal function by avoiding calcineurin-inhibitors in renal transplantation: a randomized trial of sirolimus vs. tacrolimus (Abstract 461).
  Larson TS, Dean PG, Griffin MD, Prieto M, Schwab TR, Cosio FG, Nyberg SL, Textor SC, Gloor JM, Stegall MD, Am J Transplant, 1/1/2004
• Elevated uric acid levels precede measurable changes in GFR or blood pressure in renal transplant patients treated with tacrolimus as compared to sirolimus (Abstract 6...
  Mahale AS, Textor SC, AbuAttieh M, Khamash HA, Taler SJ, Driscoll NL, Augustine JE, Larson TS, Gloor JM, Griffin MD, Schwab TR, Cosio FG, Stegall MD, Am J Transplant, 1/1/2004
• Predictive differences and misclassification between clinic (Dinamap), ambulatory (ABPM), and hypertension nurse (RN) blood pressure measurements in kidney recipients ...
  Textor SC, AbuAttieh M, Mahale A, Taler SJ, Driscoll N, Augustine JE, Larson TS, Gloor JM, Griffin MD, Schwab TR, Cosio FG, Stegall MD, Am J Transplant, 1/1/2004
• Living donor kidney transplantation in positive crossmatch patients at the Mayo Clinic.
  Gloor JM, Larson TS, Griffin MD, Schwab TR, Textor SC, Moore SB, DeGoey SR, Pineda AA, Stegall MD, J Am Soc Nephrol, 11/1/2003
• ABO incompatible kidney transplantation at the Mayo Clinic using both A2 and non-A2 living donors.
  Gloor JM, Pineda AA, Moore SB, Schwab TR, Griffin MD, Larson TS, Textor SC, Lager DJ, Fidler ME, Stegall MD, J Am Soc Nephrol, 11/1/2003
• Pancreas-after-kidney (PAK) transplantation: an increasingly viable alternative to simultaneous kidney-pancreas transplantation (SPK) (Abstract 0135).
  Stegall MD, Larson TS, Prieto M, Nyberg S, Textor SC, Schwab TR, Griffin MD, Rea DJ, Gloor J, Kudva Y, Transplantation, 8/1/2003
• Graft outcomes in polyomavirus-associated nephropathy - the influence of surveillance biopsy and conversion to cyclosporine (Abstract 849).
  Buehrig CK, Hamad A, Kreps MA, Lager DJ, Fidler ME, Gloor JM, Schwab TR, Cosio F, Textor SC, Stegall MD, Larson TS, Griffin MD, Am J Transplant, 1/1/2003
• Splenectomy is not necessary to prevent antibody-mediated rejection in positive crossmatch kidney transplantation (Abstract 296).
  Gloor JM, Moore SB, DeGoey SR, Larson TS, Griffin MD, Schwab TR, Textor SL, Prieto M, Nyberg SL, Velosa JA, Stegall MD, Am J Transplant, 1/1/2003
• ABO incompatible kidney transplantation using both A2 and non-A2 living donors (Abstract 191).
  Gloor JM, Moore SB, Fidler ME, Lager DJ, Pineda AA, Larson TS, Griffin MD, Schwab TR, Textor SC, Prieto M, Nyberg SL, Velosa JA, Winters JL, Grande JP, Stegall MD, Am J Transplant, 1/1/2003
• Living donor kidney transplantation in positive crossmatch patients (Abstract 190).
  Gloor JM, Moore SB, Pineda AA, Lager DL, Degoey SR, Fidler ME, Larson TS, Griffin MD, Schwab TR, Textor SL, Prieto M, Nyberg SL, Winters JL, Grande JP, Velosa JA, Steg..., Am J Transplant, 1/1/2003
• Renal function loss in chronic allograft nephropathy: results of a two-year study of mycophenoloate mofetil substitution for azaathioprine (Abstract 280).
  Griffin MD, Slezak JM, Kozel TK, Bergstralh EJ, Schwab TR, Gloor JM, Stegall MD, Larson TS, Grande JP, Velosa JA, Am J Transplant, 1/1/2003
• Frequency of polyomavirus-associated nephropathy in a randomized control trial of tacrolimus versus sirolimus-based immunosuppression (Abstract 147).
  Hamad A, Buehrig CK, Kreps MA, Lager DJ, Fidler ME, Gloor JM, Schwab TR, Textor SE, Prieto M, Larson TS, Griffin MD, Stegall MD, Am J Transplant, 1/1/2003
• Pancreas-after-kidney (PAK) transplantation with thymoglobulin induction is associated with results comparable to simultaneous kidney-pancreas transplantation (SPK) (A...
  Larson TS, Bohorquez HE, Prieto M, Nyberg SL, Textor SC, Schwab TR, Griffin MD, Stegall MD, Am J Transplant, 1/1/2003
• Avoiding calcineurin-inhibitors in renal transplantation: a randomized trial of sirolimus vs tacrolimus (Abstract 1261).
  Larson TS, Griffin MD, Prieto M, Schwab TR, Lund WJ, Nyberg SL, Textor SC, Gloor JM, Taler SJ, Stegall MD, Am J Transplant, 1/1/2003
• Is older donor age associated with adverse graft outcomes in living donor kidney transplantation? (Abstract 285).
  Pena de la Vega LS, Torres A, Bohorquez H, Gloor JM, Schwab TR, Velosa JA, Larson TS, Stegall MD, Textor SC, Griffin MD, Am J Transplant, 1/1/2003
• Hypertensive living renal donors have lower blood pressures and urinary microalbumin one year after nephrectomy (Abstract 192).
  Textor SC, Taler SJ, Prieto M, Larson TS, Griffin MD, Gloor JM, Schwab TR, Driscoll NL, Augustine JE, Sprau GL, Tibor MG, Stegall SD, Am J Transplant, 1/1/2003
• Kidney transplantation without calcineurin-inhibitors: a randomized trial of sirolimus vs tacrolimus (Abstract 396).
  Larson TS, Velosa JA, Prieto M, Lund WJ, Griffin MD, Gloor JM, Nyberg SL, Schwab TR, Textor SC, Kremers WK, Stegall MD, Am J Transplant, 1/1/2002
• Join now to see all

Lectures

• Internal Medicine Board Review (Lecturer) 
  1/1/2015
• MMSII Pharmacology and Therapeutics Course 
  Rochester, MN - 1/1/2015
• Xenotransplantation Research 
  Scottsdale, AZ - 11/1/1998
• 5th National Congress of Internal Medicine 
  Quito, Ecuador - 5/1/1998
• A Look in the Future: Managing Acute Renal Failure 
  Mayo Clinic, Rochester, MN - 9/1/1997
• A Look in the Future: the Role of Growth Factors 
  Mayo Clinic, Rochester, MN - 9/1/1997
• Joint Meeting of Mayo Clinic and Royal College of Surgeons 
  Dublin, Ireland - 6/1/1996
• Serologic Diagnosis of Renal Disease 
  Minneapolis, MN - 9/1/1994
• Update in Internal Medicine Course 
  Vienna, Austria - 6/1/1994
• Mayo Nephrology Collaborative Group 
  Amelia Island, FL - 3/1/1994
• Nephrology 
  Thailand - 1/1/1992
• Selected Topics in Internal Medicine 
  San Diego, CA - 1/1/1992
• Internal Medicine Board Review 
  Chicago, IL - 1/1/1991
• MMSIII Pathophysiology Course 
  Rochester, MN - 1/1/1991
• Nurse Anesthetist Course 
  Rochester, MN - 1/1/1991
• Acute Renal Failure 
  Rochester, MN - 1/1/1991
• Medical Grand Rounds 
  Scottsdale, AZ - 1/1/1990
• Selected Topics in Endocrinology, Hypertension, and Nephrology 
  Kauai, HI - 1/1/1990
• Fluid & Electrolyte, Acid Base Balance 
  Rochester, MN - 1/1/1987
• Clinical Uses of Atrial Natriuretic Factor 
  Rochester, MN - 1/1/1987
• Emergencies in Medicine 
  Rochester, MN - 1/1/1986
• Internal Medicine Medical Knowledge Self-Assessment Program in Nephrology 
  Rochester, MN - 1/1/1986
• Internal Medicine Grand Rounds 
  Rochester, MN - 1/1/1986
• Current Concepts of Atrial Peptides 
  Rochester, MN - 1/1/1985
• Join now to see all